Research ExplorerScientific StaffVolkmar Müller Publications

Prof.Dr.med. ID: 71876

Volkmar Müller

graph of relations
Affiliations
301 - 350 out of 401Page size: 50

Publications

  1. 2013

  2. Gastropleural fistula in a patient with recurrent ovarian cancer receiving combination therapy with Carboplatin, gemcitabine, and bevacizumab

    Dohrmann, T., Kutup, A., Mahner, S., Müller, V., Jänicke, F., Izbicki, J. & Vashist, Y. K., 20.04.2013, In: J CLIN ONCOL. 31, 12, p. e208-10

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)

    Pestalozzi, B. C., Holmes, E., de Azambuja, E., Metzger-Filho, O., Hogge, L., Scullion, M., Láng, I., Wardley, A., Lichinitser, M., Sanchez, R. I. L., Müller, V., Dodwell, D., Gelber, R. D., Piccart-Gebhart, M. J. & Cameron, D., 01.03.2013, In: LANCET ONCOL. 14, 3, p. 244-8 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

    Harbeck, N., Beckmann, M. W., Rody, A., Schneeweiss, A., Müller, V., Fehm, T., Marschner, N., Gluz, O., Schrader, I., Heinrich, G., Untch, M. & Jackisch, C., 01.03.2013, In: BREAST CARE. 8, 1, p. 49-55 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients

    Babayan, A., Hannemann, J., Spötter, J., Müller, V., Pantel, K. & Joosse, S. A., 01.01.2013, In: PLOS ONE. 8, 9, p. e75038

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer

    Mathey, S., Graeser, M. K., Zu Eulenburg, C., Woelber, L., Trillsch, F., Jänicke, F., Müller, V., Milde-Langosch, K. & Mahner, S., 01.01.2013, In: ONCOLOGY-BASEL. 85, 2, p. 69-77 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.

    Bidard, F-C., Fehm, T., Ignatiadis, M., Smerage, J. B., Alix-Panabières, C., Janni, W., Messina, C., Paoletti, C., Müller, V., Hayes, D. F., Piccart, M. & Pierga, J-Y., 2013, In: CANCER METAST REV. 32, 1-2, p. 179-188 1-2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. HER2-positive Mammakarzinome

    Müller, V., 2013, Colloqium Senologie 2013. Untch, M., Harbeck, N., Thomssen, C. & Costa, S. D. (eds.). 1 ed. München: Agilium Verlag und Gesundheitsakademie GmbH, p. 115-132 18 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  9. Impressions from the san antonio breast cancer symposium december 2012

    Müller, V., Fehm, T., Kümmel, S., Liedtke, C., Rack, B. & Steger, G., 2013, In: BREAST CARE. 8, 1, p. 77-83

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  10. Neoadjuvante Therapie des Mammakarzinoms

    Müller, V. & Harbeck, N., 2013, Aktuelle Empfehlungen zur Prävention, Diagnostik und Therapie früher und fortgeschrittener Mammakarzinome. Scharl, A. (ed.). 6 ed. München: W. Zuckschwerdt Verlag, p. 151-165 15 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  11. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

    Burandt, E. C., Jens, G., Holst, F., Jänicke, F., Müller, V., Quaas, A., Choschzick, M., Wilczak, W., Terracciano, L., Simon, R., Sauter, G. & Lebeau, A., 2013, In: BREAST CANCER RES TR. 137, 3, p. 745-753 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients

    Schröder, C., Milde-Langosch, K., Gebauer, F., Schmid, K., Müller, V., Wirtz, R. M., Meyer-Schwesinger, C., Schluter, H., Sauter, G. & Schumacher, U., 2013, In: J CANCER RES CLIN. 139, p. 1745-1755 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

    Wallwiener, M., Hartkopf, A. D., Baccelli, I., Riethdorf, S., Schott, S., Pantel, K., Marmé, F., Sohn, C., Trumpp, A., Rack, B., Aktas, B., Solomayer, E-F., Müller, V., Janni, W., Schneeweiss, A. & Fehm, T. N., 2013, In: BREAST CANCER RES TR. 137, 2, p. 503-510 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

    Milde-Langosch, K., Karn, T., Müller, V., Witzel, I., Rody, A., Schmidt, M. & Wirtz, R. M., 2013, In: BREAST CANCER RES TR. 137, 1, p. 57-67 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Zirkulierende Tumorzellen in der Diagnose und Therapie des Mammakarzinoms

    Fehm, T., Hartkopf, A. D., Janni, W., Solomayer, E., Rack, B. & Müller, V., 2013, In: BREAST CARE. 8, p. 375-377

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  16. 2012

  17. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.

    Schmidt, M., Hellwig, B., Hammad, S., Othman, A., Lohr, M., Chen, Z., Boehm, D., Gebhard, S., Petry, I., Lebrecht, A., Cadenas, C., Marchan, R., Stewart, J. D., Solbach, C., Holmberg, L., Edlund, K., Kultima, H. G., Rody, A., Berglund, A., Lambe, M., Isaksson, A., Botling, J., Karn, T., Müller, V., Gerhold-Ay, A., Cotarelo, C., Sebastian, M., Kronenwett, R., Bojar, H., Lehr, H-A., Sahin, U., Koelbl, H., Gehrmann, M., Micke, P., Rahnenführer, J. & Hengstler, J. G., 2012, In: CLIN CANCER RES. 18, 9, p. 2695-2703 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.

    Joosse, S., Hannemann, J., Spötter, J., Bauche, A., Andreas, A., Müller, V. & Pantel, K., 2012, In: CLIN CANCER RES. 18, 4, p. 993-1003 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.

    Witzel, I., Schröder, C., Müller, V., Zander, H., Tachezy, M., Henningsen, M., Jänicke, F. & Milde-Langosch, K., 2012, In: ONCOLOGY-BASEL. 82, 6, p. 305-312 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

    Schwarzenbach, H., Milde-Langosch, K., Steinbach, B., Müller, V. & Pantel, K., 2012, In: BREAST CANCER RES TR. 134, 3, p. 933-941 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

    Karn, T., Pusztai, L., Ruckhäberle, E., Liedtke, C., Müller, V., Schmidt, M., Metzler, D., Wang, J., Coombes, K. R., Gätje, R., Hanker, L., Solbach, C., Ahr, A., Holtrich, U., Rody, A. & Kaufmann, M., 2012, In: EUR J CANCER. 48, 1, p. 12-23 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.

    Witzel, I., Loibl, S., von Minckwitz, G., Eidtmann, H., Fehm, T., Khandan, F., Schmatloch, S., Hauschild, M., Bischoff, J., Fasching, P. A., Mau, C., Schem, C., Rack, B., Meinhold-Heerlein, I., Liedtke, C., Karn, T., Huober, J., Zu Eulenburg, C. G., Issa-Nummer, Y., Untch, M. & Müller, V., 2012, In: BRIT J CANCER. 107, 6, p. 956-960 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.

    Müller, V., Riethdorf, S., Rack, B., Janni, W., Fasching, P. A., Solomayer, E., Aktas, B., Kasimir-Bauer, S., Pantel, K., Fehm, T. & Group, O. B. O. T. DETECT. S., 2012, In: BREAST CANCER RES. 14, 4, p. 118 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.

    Henningsen, M., Kress, K., Kersten, J. F., Kilic, E., Choschzick, M., Zander, H., Müller, V., Mahner, S., Jänicke, F., Wölber, L. & Milde-Langosch, K., 2012, In: BMC CANCER. 12, p. 140

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Relevance of PTEN loss in brain metastasis formation in breast cancer patients.

    Wikman, H., Lamszus, K., Detels, N., Uslar, L., Wrage, M., Benner, C., Hohensee, I., Ylstra, B., Eylmann, K., Zapatka, M., Sauter, G., Kemming, D., Glatzel, M., Müller, V., Westphal, M. & Pantel, K., 2012, In: BREAST CANCER RES. 14, 2, p. 49 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Treatment of breast cancer during pregnancy: an observational study.

    Loibl, S., Han, S. N., von Minckwitz, G., Bontenbal, M., Ring, A., Giermek, J., Fehm, T., Kristel, V. C., Linn, S. C., Schlehe, B., Gziri, M. M., Westenend, P. J., Müller, V., Heyns, L., Rack, B., Ben, V. C., Harbeck, N., Lenhard, M., Halaska, M. J., Kaufmann, M., Nekljudova, V. & Amant, F., 2012, In: LANCET ONCOL. 13, 9, p. 887-896 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel Discussion.

    Jackisch, C., Lück, H-J., Untch, M., Bischoff, J., Müller, V., Schmidt, M., Thill, M. & Kiechle, M., 2012, In: BREAST CARE. 7, 2, p. 137-143 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. 2011

  29. A clinically relevant gene signature in triple negative and basal-like breast cancer.

    Rody, A., Karn, T., Liedtke, C., Pusztai, L., Ruckhaeberle, E., Hanker, L., Gaetje, R., Solbach, C., Ahr, A., Metzler, D., Schmidt, M., Müller, V., Holtrich, U. & Kaufmann, M., 2011, In: BREAST CANCER RES. 13, 5, p. 97 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

    Filipits, M., Rudas, M., Jakesz, R., Dubsky, P., Fitzal, F., Singer, C. F., Dietze, O., Greil, R., Jelen, A., Sevelda, P., Freibauer, C., Müller, V., Jänicke, F., Schmidt, M., Kölbl, H., Rody, A., Kaufmann, M., Schroth, W., Brauch, H., Schwab, M., Fritz, P., Weber, K. E., Feder, I. S., Hennig, G., Kronenwett, R., Gehrmann, M., Gnant, M. & Investigators, EP., 2011, In: CLIN CANCER RES. 17, 18, p. 6012-6020 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.

    Roth, C., Pantel, K., Müller, V., Rack, B., Kasimir-Bauer, S., Janni, W. & Schwarzenbach, H., 2011, In: BMC CANCER. 11, p. 4

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.

    Hein, S., Müller, V., Köhler, N., Wikman, H., Krenkel, S., Streichert, T., Schweizer, M., Riethdorf, S., Assmann, V., Henningsen, M., Beck, K., Issa, R., Jänicke, F., Pantel, K. & Milde-Langosch, K., 2011, In: BREAST CANCER RES TR. 129, 2, p. 347-360 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer.

    Wölber, L., Kress, K., Kersten, J. F., Choschzick, M., Kilic, E., Herwig, U., Lindner, C., Schwarz, J., Jänicke, F., Mahner, S., Milde-Langosch, K., Müller, V. & Henningsen, M., 2011, In: BMC CANCER. 11, p. 12

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Circulating microRNAs: promising breast cancer biomarkers - author´s response

    Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K. & Schwarzenbach, H., 2011, In: BREAST CANCER RES. 13, 1, p. 403

    Research output: SCORING: Contribution to journal › Newspaper articles › Transfer

  35. Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

    Aktas, B., Müller, V., Tewes, M., Zeitz, J., Kasimir-Bauer, S., Loehberg, C. R., Rack, B., Schneeweiss, A. & Fehm, T., 2011, In: GYNECOL ONCOL. 122, 2, p. 356-360 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).

    Loibl, S., Müller, V., von Minckwitz, G., Conrad, B., Koehne, C-H., Kremers, S., Forstbauer, H., Linder, M., Nekljudova, V. & Moebus, V., 2011, In: SUPPORT CARE CANCER. 19, 11, p. 1789-1795 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.

    Schwarzenbach, H., Müller, V., Milde-Langosch, K., Steinbach, B. & Pantel, K., 2011, In: MOL BIOSYST. 7, 10, p. 2848-2854 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.

    Karn, T., Ruckhäberle, E., Hanker, L., Müller, V., Schmidt, M., Solbach, C., Gätje, R., Gehrmann, M., Holtrich, U., Kaufmann, M. & Rody, A., 2011, In: BREAST CANCER RES TR. 130, 2, p. 409-420 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

    Karn, T., Pusztai, L., Holtrich, U., Iwamoto, T., Shiang, C. Y., Schmidt, M., Müller, V., Solbach, C., Gaetje, R., Hanker, L., Ahr, A., Liedtke, C., Ruckhäberle, E., Kaufmann, M. & Rody, A., 2011, In: PLOS ONE. 6, 12, p. 28403 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials.

    von Minckwitz, G., Untch, M., Nüesch, E., Loibl, S., Kaufmann, M., Kümmel, S., Fasching, P. A., Eiermann, W., Blohmer, J-U., Costa, S. D., Mehta, K., Hilfrich, J., Jackisch, C., Gerber, B., Andreas, D. B., Huober, J., Hanusch, C., Konecny, G., Fett, W., Stickeler, E., Harbeck, N., Müller, V. & Jüni, P., 2011, In: BREAST CANCER RES TR. 125, 1, p. 145-156 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.

    Witzel, I., Kantelhardt, E. J., Milde-Langosch, K., Henningsen, M., Zeitz, J., Harbeck, N., Jänicke, F. & Müller, V., 2011, In: ONKOLOGIE. 34, 6, p. 304-308 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.

    Choschzick, M., Oosterwijk, E., Müller, V., Wölber, L., Simon, R., Moch, H. & Tennstedt, P., 2011, In: VIRCHOWS ARCH. 459, 2, p. 193-200 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

    Untch, M., Fasching, P. A., Konecny, G. E., Hasmüller, S., Lebeau, A., Kreienberg, R., Camara, O., Müller, V., Andreas, D. B., Kühn, T., Stickeler, E., Harbeck, N., Höss, C., Kahlert, S., Beck, T., Fett, W., Mehta, K. M., von Minckwitz, G. & Loibl, S., 2011, In: J CLIN ONCOL. 29, 25, p. 3351-3357 25.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.

    Untch, M., Fasching, P. A., Konecny, G. E., von Koch, F., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Schuster, T., Nekljudova, V., Lebeau, A., Loibl, S., von Minckwitz, G. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1988-1998 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis.

    Untch, M., von Minckwitz, G., Konecny, G. E., Conrad, U., Fett, W., Kurzeder, C., Lück, H-J., Stickeler, E., Urbaczyk, H., Liedtke, B., Beckmann, M. W., Salat, C., Harbeck, N., Müller, V., Schmidt, M., Hasmüller, S., Lenhard, M., Nekljudova, V., Lebeau, A., Loibl, S., Fasching, P. A. & Investigators, A. G. O. PREPARE., 2011, In: ANN ONCOL. 22, 9, p. 1999-2006 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.

    Schröder, C., Witzel, I., Müller, V., Krenkel, S., Wirtz, R. M., Jänicke, F., Schumacher, U. & Milde-Langosch, K., 2011, In: J CANCER RES CLIN. 137, 8, p. 1193-1201 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.

    Müller, V., Riethdorf, S., Rack, B., Janni, W., Fasching, P. A., Solomayer, E., Aktas, B., Kasimir-Bauer, S., Zeitz, J., Pantel, K., Fehm, T. & Group, DETECT. S., 2011, In: BREAST CANCER RES. 13, 4, p. 71 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin

    Henningsen, M., Kilic, E., Koehler, N., Löning, T., Witzel, I., Hagel, C., Höller, S., Kersten, J. F., Müller, V., Jänicke, F. & Milde-Langosch, K., 2011, In: J CLIN PATHOL. 64, 2, p. 146-152 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.

    Kock, L., Mahner, S., Choschzick, M., Zu Eulenburg, C. G., Milde-Langosch, K., Schwarz, J., Jänicke, F., Müller, V. & Wölber, L., 2011, In: INT J GYNECOL CANCER. 21, 1, p. 141-148 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. 2010

  51. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.

    Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K. & Schwarzenbach, H., 2010, In: BREAST CANCER RES. 12, 6, p. 90 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

    Henningsen, M., Wirtz, R. M., Kalogeras, K. T., Milde-Langosch, K., Schmidt, M., Witzel, I., Eleftheraki, A. G., Papadimitriou, C., Jänicke, F., Briassoulis, E., Pectasides, D., Rody, A., Fountzilas, G. & Müller, V., 2010, In: BRIT J CANCER. 103, 7, p. 1048-1056 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

    Witzel, I., Milde-Langosch, K., Wirtz, R. M., Roth, C., Henningsen, M., Mahner, S., Zu Eulenburg, C. G., Jänicke, F. & Müller, V., 2010, In: J CANCER RES CLIN. 136, 11, p. 1709-1718 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

    Riethdorf, S., Müller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T., Schrader, I., Hilfrich, J., Holms, F., Tesch, H., Eidtmann, H., Untch, M., von Minckwitz, G. & Pantel, K., 2010, In: CLIN CANCER RES. 16, 9, p. 2634-2645 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...3 4 5 6 7 8 9 Next